Abstract P212: Benchmark Analysis of Genetic Testing Practice Patterns in a Real-World Population of Patients Receiving Clopidogrel or Prasugrel Therapy

MLA

Barnabie C Agatep, et al. “Abstract P212: Benchmark Analysis of Genetic Testing Practice Patterns in a Real-World Population of Patients Receiving Clopidogrel or Prasugrel Therapy.” Circulation: Cardiovascular Quality and Outcomes, vol. 4, Nov. 2011. EBSCOhost, https://doi.org/10.1161/circoutcomes.4.suppl_2.ap212.

APA

Barnabie C Agatep, Cynthia H Ewel, Vivian Herrera, Eric J. Stanek, Scott L. Charland, & Nathan J. Markward. (2011). Abstract P212: Benchmark Analysis of Genetic Testing Practice Patterns in a Real-World Population of Patients Receiving Clopidogrel or Prasugrel Therapy. Circulation: Cardiovascular Quality and Outcomes, 4. https://doi.org/10.1161/circoutcomes.4.suppl_2.ap212

Chicago

Barnabie C Agatep, Cynthia H Ewel, Vivian Herrera, Eric J. Stanek, Scott L. Charland, and Nathan J. Markward. 2011. “Abstract P212: Benchmark Analysis of Genetic Testing Practice Patterns in a Real-World Population of Patients Receiving Clopidogrel or Prasugrel Therapy.” Circulation: Cardiovascular Quality and Outcomes 4 (November). doi:10.1161/circoutcomes.4.suppl_2.ap212.